Clinical Trial Update: Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the effect of ivabradine in patients with Stage D heart failure and cardiogenic shock on dobutamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure

Drugs mentioned

• Dobutamine (dobutamine)
• IVABRADINE

Snippet

Sponsor: Loyola University | Conditions: Heart Failure, Cardiogenic Shock | Phase 4 | Status: UNKNOWN